Wells Fargo’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59M | Sell |
90,060
-1,434
| -2% | -$41.2K | ﹤0.01% | 2719 |
|
|
2025
Q1 | $3.07M | Sell |
91,494
-9,422
| -9% | -$316K | ﹤0.01% | 2488 |
|
|
2024
Q4 | $5.16M | Buy |
100,916
+16,025
| +19% | +$819K | ﹤0.01% | 2119 |
|
|
2024
Q3 | $4.34M | Buy |
84,891
+11,971
| +16% | +$612K | ﹤0.01% | 2215 |
|
|
2024
Q2 | $3.27M | Buy |
72,920
+4,080
| +6% | +$183K | ﹤0.01% | 2350 |
|
|
2024
Q1 | $3.22M | Buy |
68,840
+47,898
| +229% | +$2.24M | ﹤0.01% | 2343 |
|
|
2023
Q4 | $745K | Sell |
20,942
-30,850
| -60% | -$1.1M | ﹤0.01% | 3286 |
|
|
2023
Q3 | $1.54M | Buy |
51,792
+7,657
| +17% | +$228K | ﹤0.01% | 2783 |
|
|
2023
Q2 | $795K | Buy |
44,135
+13,151
| +42% | +$237K | ﹤0.01% | 3430 |
|
|
2023
Q1 | $498K | Buy |
30,984
+30,567
| +7,330% | +$491K | ﹤0.01% | 3614 |
|
|
2022
Q4 | $7.63K | Sell |
417
-559
| -57% | -$10.2K | ﹤0.01% | 5326 |
|
|
2022
Q3 | $19K | Sell |
976
-545
| -36% | -$10.6K | ﹤0.01% | 5089 |
|
|
2022
Q2 | $27K | Sell |
1,521
-4,635
| -75% | -$82.3K | ﹤0.01% | 5009 |
|
|
2022
Q1 | $135K | Sell |
6,156
-15,959
| -72% | -$350K | ﹤0.01% | 4869 |
|
|
2021
Q4 | $628K | Buy |
+22,115
| New | +$628K | ﹤0.01% | 4195 |
|
|
2021
Q2 | – | Sell |
-5,195
| Closed | -$79K | – | 6586 |
|
|
2021
Q1 | $79K | Sell |
5,195
-17,998
| -78% | -$274K | ﹤0.01% | 5244 |
|
|
2020
Q4 | $327K | Buy |
23,193
+3,354
| +17% | +$47.3K | ﹤0.01% | 4715 |
|
|
2020
Q3 | $311K | Sell |
19,839
-417
| -2% | -$6.54K | ﹤0.01% | 4550 |
|
|
2020
Q2 | $355K | Buy |
20,256
+13,497
| +200% | +$237K | ﹤0.01% | 4427 |
|
|
2020
Q1 | $99K | Sell |
6,759
-2,516
| -27% | -$36.9K | ﹤0.01% | 4867 |
|
|
2019
Q4 | $232K | Sell |
9,275
-14,034
| -60% | -$351K | ﹤0.01% | 4717 |
|
|
2019
Q3 | $351K | Buy |
23,309
+3,110
| +15% | +$46.8K | ﹤0.01% | 4473 |
|
|
2019
Q2 | $505K | Buy |
20,199
+9,999
| +98% | +$250K | ﹤0.01% | 4260 |
|
|
2019
Q1 | $232K | Buy |
10,200
+95
| +0.9% | +$2.16K | ﹤0.01% | 4676 |
|
|
2018
Q4 | $303K | Buy |
10,105
+6,720
| +199% | +$202K | ﹤0.01% | 4505 |
|
|
2018
Q3 | $97K | Buy |
+3,385
| New | +$97K | ﹤0.01% | 5129 |
|